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Tumor hypoxia is a characteristic feature of solid tumors, which will lead to enhanced tumor metastasis and 
resistance to radiation therapy. Many strategies have been proposed to increase the overall functional 
oxygenation and radiosensitivity of hypoxic tumors, by delivering more oxygen to the hypoxic tumor or reducing 
the oxygen consumption within the tumor by using anti-hypoxia agents. Preliminary data indicated that FDA 
approved drug papaverine could effectively reduce the mitochondrial oxygen consumption rate of human lung 
tumor cells (A549) in vitro and thus can reduce hypoxia-induced radiation resistance. However, the real-time 
tumor oxygenation response to papaverine in vivo remains to be characterized, and the optimal temporal window 
for delivery of radiation after anti-hypoxia therapy requires to be determined. Optical spectroscopy, particularly 
frequency-domain near-infrared spectroscopy (FD-NIRS), provides a new noninvasive approach for continuously 
monitoring tumor hypoxia in vivo. 
 
In this study, we have developed a side-firing fiber optic surface sensor and an FD-NIRS instrument with four 
laser wavelengths for quantifying tumor oxygenation in response to papaverine in human tumor xenograft 
models. Nude mice bearing subcutaneous A549 xenografts on the flank were used for tumor hypoxia study. 
Heathy nude mice without tumors were assigned as a control. The side-firing surface sensor was attached to the 
skin above the tumor or the muscle tissue on the flank of the animals. All animals were administrated with a 
constant flow of compressed air mixed with isoflurane throughout the experiments. 30-minute baseline 
measurement prior to injection, followed by 120-minute continuous measurement after injection were conducted 
for each animal. Intravenous tail injection of papaverine at 2 mg/kg or the same volume of 0.9% saline solution 
was applied to the animals. Typical results are presented in Fig. 1. The baseline measurement became stable 
with a small fluctuation of ±2% in ~15 minutes when the animals became fully anesthetized and breathed 
regularly. The slightly increase in tissue oxygenation (SO2) prior to injection was mainly due to injection 
preparing procedures like tail heating and injecting attempts. Significant increase in SO2 was observed for A549 
tumors in response to papaverine (from ~48% to~57%). SO2 reached the highest reading within 20 minutes 
after papaverine injection and remained at the highest for 30 minutes. In comparison, the difference in SO2 
between the post papaverine injection and the baseline readings for muscle tissue was small. Similarly, the 
















An immediate drop right after papaverine injection was also recorded, which was likely due to the acute pain 
caused by the drug injection. In conclusion, according to our study, the FD-NIRS instrument with a side-firing 
fiber optic sensor can noninvasively and continuously quantify tumor oxygenation during anti-hypoxia treatment, 
and thus provide an effective feedback on the effectiveness of the drug and the optimal temporal window for 
delivery of irradiation. 
Figure 1 – Typical tissue oxygenation 
change of A549 tumor and normal 
muscle tissue in response to papaverine 
(PPV) and saline 
